Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration
- PMID: 32581723
- PMCID: PMC7296093
- DOI: 10.3389/fncel.2020.00162
Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration
Abstract
Microglia are brain macrophages that mediate neuroinflammation and contribute to and protect against neurodegeneration. The terminal sugar residue of all glycoproteins and glycolipids on the surface of mammalian cells is normally sialic acid, and addition of this negatively charged residue is known as "sialylation," whereas removal by sialidases is known as "desialylation." High sialylation of the neuronal cell surface inhibits microglial phagocytosis of such neurons, via: (i) activating sialic acid receptors (Siglecs) on microglia that inhibit phagocytosis and (ii) inhibiting binding of opsonins C1q, C3, and galectin-3. Microglial sialylation inhibits inflammatory activation of microglia via: (i) activating Siglec receptors CD22 and CD33 on microglia that inhibit phagocytosis and (ii) inhibiting Toll-like receptor 4 (TLR4), complement receptor 3 (CR3), and other microglial receptors. When activated, microglia release a sialidase activity that desialylates both microglia and neurons, activating the microglia and rendering the neurons susceptible to phagocytosis. Activated microglia also release galectin-3 (Gal-3), which: (i) further activates microglia via binding to TLR4 and TREM2, (ii) binds to desialylated neurons opsonizing them for phagocytosis via Mer tyrosine kinase, and (iii) promotes Aβ aggregation and toxicity in vivo. Gal-3 and desialylation may increase in a variety of brain pathologies. Thus, Gal-3 and sialidases are potential treatment targets to prevent neuroinflammation and neurodegeneration.
Keywords: aging; desialylation; galectin-3; microglia; neurodegeneration; phagocytosis; sialic acid.
Copyright © 2020 Puigdellívol, Allendorf and Brown.
Figures



Similar articles
-
Activated microglia desialylate their surface, stimulating complement receptor 3-mediated phagocytosis of neurons.Glia. 2020 May;68(5):989-998. doi: 10.1002/glia.23757. Epub 2019 Nov 27. Glia. 2020. PMID: 31774586 Free PMC article.
-
Control of Innate Immunity by Sialic Acids in the Nervous Tissue.Int J Mol Sci. 2020 Jul 31;21(15):5494. doi: 10.3390/ijms21155494. Int J Mol Sci. 2020. PMID: 32752058 Free PMC article. Review.
-
Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine Kinase.J Immunol. 2017 Jun 15;198(12):4792-4801. doi: 10.4049/jimmunol.1502532. Epub 2017 May 12. J Immunol. 2017. PMID: 28500071 Free PMC article.
-
Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll-like Receptor 4.J Neurochem. 2020 Nov;155(4):403-416. doi: 10.1111/jnc.15024. Epub 2020 May 4. J Neurochem. 2020. PMID: 32279315
-
Sialylation acts as a checkpoint for innate immune responses in the central nervous system.Glia. 2021 Jul;69(7):1619-1636. doi: 10.1002/glia.23945. Epub 2020 Dec 19. Glia. 2021. PMID: 33340149 Review.
Cited by
-
primiReference: a reference for analysis of primary-microRNA expression in single-nucleus sequencing data.J Genet Genomics. 2023 Feb;50(2):108-121. doi: 10.1016/j.jgg.2022.10.003. Epub 2022 Nov 9. J Genet Genomics. 2023. PMID: 36371075 Free PMC article.
-
An insight into new glycotherapeutics in glial inflammation: Understanding the role of glycosylation in mitochondrial function and acute to the chronic phases of inflammation.CNS Neurosci Ther. 2023 Jan;29(1):429-444. doi: 10.1111/cns.14016. Epub 2022 Nov 15. CNS Neurosci Ther. 2023. PMID: 36377513 Free PMC article.
-
Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State.Front Mol Neurosci. 2021 Mar 4;14:620090. doi: 10.3389/fnmol.2021.620090. eCollection 2021. Front Mol Neurosci. 2021. PMID: 33746710 Free PMC article.
-
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview.World J Diabetes. 2021 Oct 15;12(10):1731-1739. doi: 10.4239/wjd.v12.i10.1731. World J Diabetes. 2021. PMID: 34754374 Free PMC article. Review.
-
Development and validation of Galectin-3 and CVAI-based model for predicting cognitive impairment in type 2 diabetes.J Endocrinol Invest. 2025 Apr;48(4):1017-1031. doi: 10.1007/s40618-024-02506-z. Epub 2024 Nov 20. J Endocrinol Invest. 2025. PMID: 39565520
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous